CIPLA FDA Approval ANDA 207684

ANDA 207684

CIPLA

FDA Drug Application

Application #207684

Application Sponsors

ANDA 207684CIPLA

Marketing Status

Prescription001

Application Products

001SUSPENSION;ORAL50MG/5ML0NEVIRAPINENEVIRAPINE

FDA Submissions

UNKNOWN; ORIG1AP2017-08-03STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAA

CDER Filings

CIPLA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 207684
            [companyName] => CIPLA
            [docInserts] => ["",""]
            [products] => [{"drugName":"NEVIRAPINE","activeIngredients":"NEVIRAPINE","strength":"50MG\/5ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/03\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"12\/21\/2018","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2018-12-21
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.